Neogenomics (NEO) Total Debt Growth (1y) (2011 - 2020)
Neogenomics (NEO) Total Debt Growth (1y) (2011 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 22.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 48.73% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -20.41% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -4.01% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 3.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -72.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -0.07% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -3.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -0.37% |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.85% |
| Dec 31, 2019 | 1.12% |
| Sep 30, 2019 | 2.37% |
| Jun 30, 2019 | 1.18% |
| Mar 31, 2019 | 35.20% |
| Dec 31, 2018 | 36.08% |
| Sep 30, 2018 | 35.96% |
| Jun 30, 2018 | 35.71% |
| Mar 31, 2018 | -11.22% |
| Dec 31, 2017 | -4.78% |
| Sep 30, 2017 | 34.99% |
| Jun 30, 2017 | 36.68% |
| Mar 31, 2017 | 40.36% |
| Dec 31, 2016 | 20.90% |
| Sep 30, 2014 | 90.53% |
| Dec 31, 2013 | -10.43% |
| Dec 31, 2012 | 116.98% |
| Jun 30, 2012 | 67.40% |
| Dec 31, 2011 | 13.25% |